JohnMBennettMD

PubMed

• 4 citations
  An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.
  Maximilian Stahl, Omar Abdel-Wahab, Andrew H Wei, Michael R Savona, Mina L Xu, Zhuoer Xie, Justin Taylor, Daniel Starczynowski, Guillermo F Sanz, David A Sallman, Vale...> ;Blood Advances. 2023 Jun 27
• 1 citations
  ICC-2022 versus WHO-2022 classification systems for acute leukemias and myeloid neoplasms: The perspective from two classical morphologists.
  Gina Zini, John M Bennett> ;American Journal of Hematology. 2023 Aug 1
• 1 citations
  Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis.
  James M Foran, Zhuoxin Sun, Catherine Lai, Hugo F Fernandez, Larry D Cripe, Rhett P Ketterling, Janis Racevskis, Selina M Luger, Elisabeth Paietta, Hillard M Lazarus, ...> ;Cancer. 2023 Aug 15
• 13 citations
  Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.
  Amer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A Sekeres, David P Steensma, Uwe Platzbecker, Sanam Loghavi, Jacqueline Boultwood, Rafael Bejar, John M ...> ;Leukemia. 2022 Dec 1
• 14 citations
  Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update.
  Akriti G Jain, Ling Zhang, John M Bennett, Rami Komrokji> ;Annals of Laboratory Medicine. 2022 May 1
• 44 citations
  NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.
  Peter L Greenberg, Richard M Stone, Aref Al-Kali, John M Bennett, Uma Borate, Andrew M Brunner, Wanxing Chai-Ho, Peter Curtin, Carlos M de Castro, H Joachim Deeg, Amy ...> ;Journal of the National Comprehensive Cancer Network. 2022 Feb 1
• 5 citations
  The WHO 2016 diagnostic criteria for Acute Myeloid leukemia with myelodysplasia related changes (AML-MRC) produce a very heterogeneous entity: A retrospective analysis...
  Jennifer Kaivers, J. Peters, C. Rautenberg, T. Schroeder, Guido Kobbe, Barbara Hildebrandt, Rainer Haas, Ulrich Germing, John M. Bennett> ;Leukemia Research. 2021 Nov 26
• 72 citations
  Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and ...
  Courtney Dinardo, Andre C. Schuh, Eytan M. Stein, Pau Montesinos, Andrew H. Wei, Stéphane de Botton, Amer M. Zeidan, Amir T. Fathi, Hagop M. Kantarjian, John M. Bennet...> ;The Lancet. Oncology. 2021 Oct 18
• 1 citations
  Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
  Elsa Bernard, Yasuhito Nannya, Robert P Hasserjian, Sean M Devlin, Heinz Tuechler, Juan S Medina-Martinez, Tetsuichi Yoshizato, Yusuke Shiozawa, Ryunosuke Saiki, Luca ...> ;Nature Medicine. 2021 May 1
• 1 citations
  Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
  Elsa Bernard, Yasuhito Nannya, Robert P Hasserjian, Sean M Devlin, Heinz Tuechler, Juan S Medina-Martinez, Tetsuichi Yoshizato, Yusuke Shiozawa, Ryunosuke Saiki, Luca ...> ;Nature Medicine. 2021 Mar 1
• 17 citations
  Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin
  Alan F. List, Zhuoxin Sun, Amit Verma, John M. Bennett, Rami S. Komrokji, Kathy L. McGraw, Jaroslaw P. Maciejewski, Jessica K. Altman, Puneet S. Cheema, David F. Claxt...> ;Journal of Clinical Oncology. 2021 Jan 13
• A Case of Acute Eosinophilic Leukemia with a Novel PHF6 Mutation.
  J J Lipof, E J Huselton, Clive S. Zent, Andrew G. Evans, Bin Zhang, Paul G. Rothberg, John M. Bennett> ;Case Reports in Hematology. 2021 Jan 1
• 1 citations
  Remission of anti-TIF1γ dermatomyositis after allogeneic hematopoietic stem cell transplant for myelodysplastic syndrome
  Fatima Bawany, Bushra Tbakhi, Jason H. Mendler, Christopher T. Richardson, John M. Bennett, Omar S. Aljitawi> ;Blood Advances. 2020 Nov 24
• 11 citations
  The role of eosinophil morphology in distinguishing between reactive eosinophilia and eosinophilia as a feature of a myeloid neoplasm
  Jean E. Goasguen, John M. Bennett, Barbara J. Bain, Richard D. Brunning, Gina Zini, Maria-Teresa Vallespi, Masao Tomonaga, Clara Locher> ;British Journal of Haematology. 2020 Aug 29
• 306 citations
  Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
  Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian, Sean M. Devlin, Heinz Tuechler, Juan S. Medina-Martinez, Tetsuichi Yoshizato, Yusuke Shiozawa, Ryunosuke Saiki, Lu...> ;Nature Medicine. 2020 Aug 3
• A case of Burkitt Leukemia: Revisiting the prognostic value of lactate dehydrogenase.
  A. Bodrog, Bin Zhang, L. Liu, Carla Casulo, John M. Bennett> ;Leukemia Research. 2020 Feb 1
• 11 citations
  Decoding Bone Marrow Fibrosis in Myelodysplastic Syndromes
  Megan Melody, Najla Al Ali, Ling Zhang, Hanadi Ramadan, Eric Padron, David A. Sallman, Kendra Sweet, Jeffrey E. Lancet, Alan F. List, John M. Bennett, Rami S. Komrokji> ;Clinical Lymphoma, Myeloma & Leukemia. 2016 Dec 2
• 79 citations
  Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
  Peter Valent, Attilio Orazi, Michael R. Savona, Mrinal M. Patnaik, Francesco Onida, Arjan A. van de Loosdrecht, Detlef Haase, Torsten Haferlach, Chiara Elena, Lisa Ple...> ;Haematologica. 2019 Oct 1
• 3 citations
  Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900.
  Hugo F. Fernandez, Zhuoxin Sun, Mark R. Litzow, Selina M. Luger, Elisabeth Paietta, Janis Racevskis, Ross L. Levine, Jay P. Patel, Omar Abdel-Wahab, Rhett P. Ketterlin...> ;Haematologica. 2019 Apr 1
• Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes.
  Judith Neukirchen-Strapatsas, Heinz Tuechler, Matteo G. Della Porta, Pierre Fenaux, Agnès Guerci, Rainer Haas, Marianna Rossi, Rosa Sapena, Wolfgang R. Sperr, Corinna ...> ;Leukemia Research. 2019 Feb 1
• 1 citations
  Hemophagocytic Lymphohistiocytosis in a Patient With Multiple Myeloma
  Caroline M. Hsu, John M. Bennett, Brea Lipe> ;Clinical Lymphoma, Myeloma & Leukemia. 2019 Jan 1
• 15 citations
  Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS
  Yasushi Miyazaki, Heinz Tuechler, Guillermo Sanz, Julie Schanz, Guillermo Garcia-Manero, Francesc Solé, John M. Bennett, David T. Bowen, Pierre Fenaux, François Dreyfu...> ;Leukemia Research. 2018 Oct 1
• 3 citations
  Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormaliti...
  Julie Schanz, Francesc Solé, Mar Mallo, E. Luño, José Cervera, Isabel Granada, Barbara Hildebrandt, Marylin L. Slovak, Kazuma Ohyashiki, Christa Fonatsch, Michael Pfei...> ;Genes, Chromosomes & Cancer. 2018 Nov 1
• 25 citations
  Clinical Utility of Classical and Nonclassical Monocyte Percentage in the Diagnosis of Chronic Myelomonocytic Leukemia.
  Chad A. Hudson, W. Richard Burack, Patricia C Leary, John M. Bennett> ;American Journal of Clinical Pathology. 2018 Aug 30
• 10 citations
  Emerging utility of flow cytometry in the diagnosis of chronic myelomonocytic leukemia.
  Chad A. Hudson, W. Richard Burack, John M. Bennett> ;Leukemia Research. 2018 Oct 1
• Join now to see all

Abstracts/Posters

• Combined Treatment with Lenalidomide and Epoetin Alfa Leads to Durable Responses in Patients with Epo-Refractory, Lower Risk Non-Deletion 5q [Del(5q)] MDS: Final Resul...
  John M. Bennett, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes
  John M. Bennett, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019